Interactions Between the Tumor Microbiota and Breast Cancer

Overview

Journal Front Cell Infect Microbiol

Date 2025 Feb 10

PMID 39926112

Authors

Hua Guo

Affiliations

Soon will be listed here.

Abstract

Breast cancer is the most common malignancy in women worldwide. Changes in the microbiota and their metabolites affect the occurrence and development of breast cancer; however, the specific mechanisms are not clear. Gut microbes and their metabolites influence the development of breast cancer by regulating the tumor immune response, estrogen metabolism, chemotherapy, and immunotherapy effects. It was previously thought that there were no microorganisms in breast tissue, but it is now thought that there are microorganisms in breast cancer that can affect the outcome of the disease. This review builds on existing research to comprehensively analyze the role of gut and intratumoral microbiota and their metabolites in the development and metastasis of breast cancer. We also explore the potential function of the microbiota as biomarkers for prognosis and therapeutic response, highlighting the need for further research to clarify the causal relationship between the microbiota and breast cancer. We hope to provide new ideas and directions for the development of new methods for breast cancer treatment.

References

Urbaniak C, Gloor G, Brackstone M, Scott L, Tangney M, Reid G . The Microbiota of Breast Tissue and Its Association with Breast Cancer. Appl Environ Microbiol. 2016; 82(16):5039-48. PMC: 4968547. DOI: 10.1128/AEM.01235-16. View

Amaro-da-Cruz A, Rubio-Tomas T, Alvarez-Mercado A . Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy. Clin Transl Oncol. 2024; 27(1):15-41. PMC: 11735593. DOI: 10.1007/s12094-024-03554-w. View

Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G . Immunological aspects of cancer chemotherapy. Nat Rev Immunol. 2007; 8(1):59-73. DOI: 10.1038/nri2216. View

Bernardo G, Le Noci V, Ottaviano E, De Cecco L, Camisaschi C, Guglielmetti S . Reduction of Staphylococcus epidermidis in the mammary tumor microbiota induces antitumor immunity and decreases breast cancer aggressiveness. Cancer Lett. 2022; 555:216041. DOI: 10.1016/j.canlet.2022.216041. View

Xue K, Li J, Huang R . The immunoregulatory role of gut microbiota in the incidence, progression, and therapy of breast cancer. Front Cell Infect Microbiol. 2024; 14:1411249. PMC: 11257971. DOI: 10.3389/fcimb.2024.1411249. View

Xue C, Chu Q, Zheng Q, Yuan X, Su Y, Bao Z . Current understanding of the intratumoral microbiome in various tumors. Cell Rep Med. 2023; 4(1):100884. PMC: 9873978. DOI: 10.1016/j.xcrm.2022.100884. View

Kwa M, Plottel C, Blaser M, Adams S . The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer. J Natl Cancer Inst. 2016; 108(8). PMC: 5017946. DOI: 10.1093/jnci/djw029. View

Arnone A, Cook K . Gut and Breast Microbiota as Endocrine Regulators of Hormone Receptor-positive Breast Cancer Risk and Therapy Response. Endocrinology. 2022; 164(1). PMC: 9923803. DOI: 10.1210/endocr/bqac177. View

Chen G, Gao C, Jiang S, Cai Q, Li R, Sun Q . Fusobacterium nucleatum outer membrane vesicles activate autophagy to promote oral cancer metastasis. J Adv Res. 2023; 56:167-179. PMC: 10834801. DOI: 10.1016/j.jare.2023.04.002. View

10.

Xuan C, Shamonki J, Chung A, DiNome M, Chung M, Sieling P . Microbial dysbiosis is associated with human breast cancer. PLoS One. 2014; 9(1):e83744. PMC: 3885448. DOI: 10.1371/journal.pone.0083744. View

11.

Zhang J, Wan S, Zhou H, Du J, Li Y, Zhu H . Programmed Nanocloak of Commensal Bacteria-Derived Nanovesicles Amplify Strong Immunoreactivity against Tumor Growth and Metastatic Progression. ACS Nano. 2024; 18(13):9613-9626. DOI: 10.1021/acsnano.3c13194. View

12.

Wang Q, Ding H, Dong G, Xu L, Jiang F, Mao Q . Bi-direction effects between microbiome and MiRNAs in carcinogenesis. J Cancer Res Clin Oncol. 2021; 147(5):1299-1305. DOI: 10.1007/s00432-021-03567-w. View

13.

Rodrigues M, Carvalho E, Pezzuto P, Rumjanek F, Dias Amoedo N . Reciprocal modulation of histone deacetylase inhibitors sodium butyrate and trichostatin A on the energy metabolism of breast cancer cells. J Cell Biochem. 2014; 116(5):797-808. DOI: 10.1002/jcb.25036. View

14.

Chen F, Yang J, Guo Y, Su D, Sheng Y, Wu Y . Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer. Front Immunol. 2023; 14:1140995. PMC: 10049788. DOI: 10.3389/fimmu.2023.1140995. View

15.

Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-263. DOI: 10.3322/caac.21834. View

16.

Smith A, Pierre J, Makowski L, Tolley E, Lyn-Cook B, Lu L . Distinct microbial communities that differ by race, stage, or breast-tumor subtype in breast tissues of non-Hispanic Black and non-Hispanic White women. Sci Rep. 2019; 9(1):11940. PMC: 6697683. DOI: 10.1038/s41598-019-48348-1. View

17.

Yang Y, Weng W, Peng J, Hong L, Yang L, Toiyama Y . Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. Gastroenterology. 2016; 152(4):851-866.e24. PMC: 5555435. DOI: 10.1053/j.gastro.2016.11.018. View

18.

Tzeng A, Sangwan N, Jia M, Liu C, Keslar K, Downs-Kelly E . Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer. Genome Med. 2021; 13(1):60. PMC: 8052771. DOI: 10.1186/s13073-021-00874-2. View

19.

Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T . Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 2020; 11(1):3259. PMC: 7320135. DOI: 10.1038/s41467-020-16967-2. View

20.

Goodwin A, DeStefano Shields C, Wu S, Huso D, Wu X, Murray-Stewart T . Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci U S A. 2011; 108(37):15354-9. PMC: 3174648. DOI: 10.1073/pnas.1010203108. View